# Tsingke Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tsingke-biotechnology-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.tsingke.net
- Total disclosed funding: $88M
- Latest round: Series B (Dec 5, 2022)
- Investors on record: 11

## About

Based in Beijing, China, and established in 2017, Tsingke Biotechnology Co., Ltd. is a biotechnology company that focuses on R&D of synthetic genomics and biosynthetic products. The company has clean production workshops, automated production equipment, and R&D center covering 12,000 square meters. Moreover, it passed the CNAS quality system certification, and national high-tech enterprise certification. As of September 2021, Tsingke Biotechnology Co., Ltd. has 1,700 employees. Besides, the company has 122 patents, including 53 invention patents. Also, the company's businesses covered China, US, and German, and served for 120,000 clients. In January 2026, Tsingke Biotechnology Co., Ltd. closed a venture funding from New Third Board (NEEQ), under ticker "874813".

The company's products and services can be divided into three categories, including synthetic genomics products and services, life science R&D equipment and raw materials, and contract development and manufacturing organization (CDMO) and contract research organization (CRO). For synthetic genomics field, the company completed about 200 million base syntheses, and manufactured 200 of nucleic acid raw materials and consumables every year. The company self-developed 768-channel blow-pressure synthetic equipment, and synthetic genomics production line that enables 160kb gene synthesis.

## Funding rounds

- Series B, Dec 5, 2022, $57M — Fortune Capital, Jolmo Capital, He'nan Investment Group, Zhongyuan Capital, Capitallink, Pine Capital
- Series A, Jan 28, 2022, $31M — SB China Venture Capital, Sharewin Investment, In Capital, Shenzhen Investment Holdings
- Angel, May 16, 2021 — E-Town International Industrial Investment

## Investors

- E-Town International Industrial Investment (https://capitalatlas.ai/funds/e-town-international-industrial-investment) — Angel
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series A
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series A
- In Capital — Series A
- Shenzhen Investment Holdings — Series A
- Fortune Capital — Series B
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series B
- He'nan Investment Group (https://capitalatlas.ai/funds/he-nan-investment-group) — Series B
- Zhongyuan Capital — Series B
- Capitallink — Series B
- Pine Capital (https://capitalatlas.ai/funds/pine-capital) — Series B